Using artificial intelligence to link genomic data to clinical outcomes in cancer care across institutions without compromising protected health information is challenging.
DanaFarber's Kenneth Kehl, MD, MPH, discusses an approach designed to preserve patient privacy. Research presented at ASCO 24. Video published 6/7/2024